AVEO Oncology's Series E Round

AVEO Oncology raised a round of funding on July 17, 2009. Investors include OSI Pharmaceuticals.

AVEO Oncology, formerly AVEO Pharmaceuticals, has built inducible, tissue-specific in vivo cancer models with which to discover drugs. Each model contains signature genetic mutations, and natural gene…

Articles about AVEO Oncology's Series E Round: